Hemophilus influenzae type b vaccine (Sinovac Dalian)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHemophilus influenzae type b vaccine (Sinovac Dalian)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSinovac (Dalian) Vaccine Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSinovac (Dalian) Vaccine Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsHaemophilus Infections

Other Information

ATC CodeN/A
Related LinksN/A